|Min SIP Amount||Not Supported|
|NAV||₹9.68 (25 Sep 2020)|
|Fund Started||08 Dec 2017|
|Fund Size||₹624 Cr|
|ICICI Bank Ltd.||Financial||Equity||7.5%|
|Multi Commodity Exchange India||Financial||Equity||6.9%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||5.9%|
|Crompton Greaves Consumer Electricals Ltd.||Cons Durable||Equity||5.6%|
|Axis Bank Ltd.||Financial||Equity||5.3%|
|Gujarat Gas Ltd.||Chemicals||Equity||5.1%|
|Eicher Motors Ltd.||Automobile||Equity||4.7%|
|Ipca Laboratories Ltd.||Healthcare||Equity||4.6%|
UTI Focussed Equity Fund Series V (1102 Days) Regular Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 08 Dec 2017. Vetri Subramaniam, Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series V (1102 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹624 Cr and the Latest NAV as of 25 Sep 2020 is ₹9.68.
The UTI Focussed Equity Fund Series V (1102 Days) Regular Growth is rated Moderately High risk.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of listed companies. The scheme will without any capitalization bias endeavour to invest in either growth stocks or value stocks or both. The Scheme will normally hold upto 30 stocks in the portfolio.